Sources Contact Advanced Search Tutorials

An Interest In:

Web News this Week

Search Archive

Some of Our Sources

View All Sources

Help Webnuz

Referal links:

June 10, 2020 04:48 pm

Coronavirus Vaccine Tracker

Researchers around the world are developing more than 135 vaccines against the coronavirus. Vaccines typically require years of research and testing before reaching the clinic, but scientists are racing to produce a safe and effective vaccine by next year. The New York Times: Work began in January with the deciphering of the SARS-CoV-2 genome. The first vaccine safety trials in humans started in March, but the road ahead remains uncertain. Some trials will fail, and others may end without a clear result. But a few may succeed in stimulating the immune system to produce effective antibodies against the virus. The story outlines the status of all the vaccines that have reached trials in humans, along with a selection of promising vaccines still being tested in cells or animals. The closest to developing the vaccine currently is a joint collaboration between the British-Swedish company AstraZeneca and the University of Oxford, and their vaccine is based on a chimpanzee adenovirus called ChAdOx1. The vaccine has gone through Phase I testing and is beginning Phase II/III testing in England and Brazil. Supported by Operation Warp Speed, the project may deliver emergency vaccines by October.

Slashdot

Slashdot was originally created in September of 1997 by Rob "CmdrTaco" Malda. Today it is owned by Geeknet, Inc..

More About this Source Visit Slashdot